News

Displaying 1 - 5 of 484 News articles. Show 5 | 10 | 20 | 40 | 60 results per page.

Read the latest news from PraxisAuril and our members. Members who wish to submit a news story for inclusion here or in our newsletter should contact website@praxisauril.org.uk.

FALLING WALLS SCIENCE START-UP OF THE YEAR 2019

28 May 2019

WHERE SCIENCE MEETS BUSINESS Falling Walls Venture is a global platform for the most promising research-based start-ups nominated by academic institutions from across the world. We provide a stage for pioneering founders who have turned science into business, creating entrepreneurial solutions for today’s most pressing challenges. The fast-paced pitch event is part of the 2-day Falling Walls Conference.

PraxisAuril and UKRI unveil the finalists for the 2019 KE Awards

28 May 2019

The KE Awards are a new initiative organised by PraxisAuril, the UK’s world-leading professional association for Knowledge Exchange (KE) practitioners, to celebrate the contribution of KE professionals in enabling and facilitating the societal and economic impact of research. Sponsored by UK Research and Innovation (UKRI), a new body creating the best possible environment for research and innovation to flourish, the KE Awards will recognise and celebrate the people behind the best KE achievements.

Member event: KE Best Practice Group kick-off meeting

21 May 2019

The Knowledge Exchange Team at Cranfield University would like to invite you to join the Knowledge Exchange Best Practice Group. This Group has been established to provide a forum where KE practitioners in higher education have an opportunity to discuss best practice, gain insights and updates on the KE landscape and build a support network. This member-led initiative provides another opportunity for PraxisAuril members to get-together and share day-to-day work experiences and expertise.

CRACK IT Solutions: In vitro platform for retinal toxicity assessment and disease modelling

14 May 2019

In vitro platform for retinal toxicity assessment and disease modelling Newcells Biotech Ltd. has developed an in vitro model of the retinal pigmented epithelium, to assess the safety and efficacy of novel ocular compounds. This technology could better predict the outcome in the human eye and reduce the number of animals used to assess the toxicity of ocular drugs. An end-user pharmaceutical company, able to provide access to ocular compounds and data with known in vivo/in vitro toxicity profiles, is sought to validate the model.

Emerging Technologies Competition: Turning promising ideas into commercial reality

30 Apr 2019

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual innovation initiative, set up to identify the most promising chemical science-based technologies and to help accelerate their commercialisation